Global Biologics Drug Development Market 2020 by Manufacturers, Countries, Type and Application, Forecast to 2025

Q: What are the significant segments operating in the market?

Market is segmented on the basis. Read More

Global Biologics Drug Development Market 2020 by Manufacturers, Countries, Type and Application, Forecast to 2025

Report ID : 7713
Published On: Feb, 2020
Pages: 118
Pharmaceuticals and Healthcare

Buy @ $3480

Biologics are defined as pharmaceutical products obtained from living cells or microorganisms.

Scope of the Report:
The global Biologics Drug Development market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Biologics Drug Development.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Biologics Drug Development market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biologics Drug Development market by product type and applications/end industries.

Market Segment by Companies, this report covers
Abbvie
Allergan
Boehringer Ingelheim
Charles River Laboratories
Catalent
Lonza Group
Amgen
Sanofi

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Clinical Manufacturing
Formulation Development
Bioassay Development
Analytical Services

Market Segment by Applications, can be divided into
In-House
Outsource
Pharma Excess

Frequently Asked Questions

What is scope of the report?

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

What are the significant segments operating in the market?

Market is segmented on the basis:

By Type
By Application
By Region
By Country
By Manufacturer

What are the vital market dynamics?

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

What does a company profile includes?

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents
1 Biologics Drug Development Market Overview
1.1 Product Overview and Scope of Biologics Drug Development
1.2 Classification of Biologics Drug Development by Types
1.2.1 Global Biologics Drug Development Revenue Comparison by Types (2019-2024)
1.2.2 Global Biologics Drug Development Revenue Market Share by Types in 2018
1.2.3 Clinical Manufacturing
1.2.4 Formulation Development
1.2.5 Bioassay Development
1.2.6 Analytical Services
1.3 Global Biologics Drug Development Market by Application
1.3.1 Global Biologics Drug Development Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 In-House
1.3.3 Outsource
1.3.4 Pharma Excess
1.4 Global Biologics Drug Development Market by Regions
1.4.1 Global Biologics Drug Development Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Biologics Drug Development Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Biologics Drug Development Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biologics Drug Development Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Biologics Drug Development Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biologics Drug Development Status and Prospect (2014-2024)
1.5 Global Market Size of Biologics Drug Development (2014-2024)
2 Manufacturers Profiles
2.1 Abbvie
2.1.1 Business Overview
2.1.2 Biologics Drug Development Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbvie Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.2 Allergan
2.2.1 Business Overview
2.2.2 Biologics Drug Development Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Allergan Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.3 Boehringer Ingelheim
2.3.1 Business Overview
2.3.2 Biologics Drug Development Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Boehringer Ingelheim Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.4 Charles River Laboratories
2.4.1 Business Overview
2.4.2 Biologics Drug Development Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Charles River Laboratories Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.5 Catalent
2.5.1 Business Overview
2.5.2 Biologics Drug Development Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Catalent Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.6 Lonza Group
2.6.1 Business Overview
2.6.2 Biologics Drug Development Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Lonza Group Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.7 Amgen
2.7.1 Business Overview
2.7.2 Biologics Drug Development Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Amgen Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.8 Sanofi
2.8.1 Business Overview
2.8.2 Biologics Drug Development Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Sanofi Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
3 Global Biologics Drug Development Market Competition, by Players
3.1 Global Biologics Drug Development Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Biologics Drug Development Players Market Share
3.2.2 Top 10 Biologics Drug Development Players Market Share
3.3 Market Competition Trend
4 Global Biologics Drug Development Market Size by Regions
4.1 Global Biologics Drug Development Revenue and Market Share by Regions
4.2 North America Biologics Drug Development Revenue and Growth Rate (2014-2019)
4.3 Europe Biologics Drug Development Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Biologics Drug Development Revenue and Growth Rate (2014-2019)
4.5 South America Biologics Drug Development Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Biologics Drug Development Revenue and Growth Rate (2014-2019)
5 North America Biologics Drug Development Revenue by Countries
5.1 North America Biologics Drug Development Revenue by Countries (2014-2019)
5.2 USA Biologics Drug Development Revenue and Growth Rate (2014-2019)
5.3 Canada Biologics Drug Development Revenue and Growth Rate (2014-2019)
5.4 Mexico Biologics Drug Development Revenue and Growth Rate (2014-2019)
6 Europe Biologics Drug Development Revenue by Countries
6.1 Europe Biologics Drug Development Revenue by Countries (2014-2019)
6.2 Germany Biologics Drug Development Revenue and Growth Rate (2014-2019)
6.3 UK Biologics Drug Development Revenue and Growth Rate (2014-2019)
6.4 France Biologics Drug Development Revenue and Growth Rate (2014-2019)
6.5 Russia Biologics Drug Development Revenue and Growth Rate (2014-2019)
6.6 Italy Biologics Drug Development Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Biologics Drug Development Revenue by Countries
7.1 Asia-Pacific Biologics Drug Development Revenue by Countries (2014-2019)
7.2 China Biologics Drug Development Revenue and Growth Rate (2014-2019)
7.3 Japan Biologics Drug Development Revenue and Growth Rate (2014-2019)
7.4 Korea Biologics Drug Development Revenue and Growth Rate (2014-2019)
7.5 India Biologics Drug Development Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Biologics Drug Development Revenue and Growth Rate (2014-2019)
8 South America Biologics Drug Development Revenue by Countries
8.1 South America Biologics Drug Development Revenue by Countries (2014-2019)
8.2 Brazil Biologics Drug Development Revenue and Growth Rate (2014-2019)
8.3 Argentina Biologics Drug Development Revenue and Growth Rate (2014-2019)
8.4 Colombia Biologics Drug Development Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Biologics Drug Development by Countries
9.1 Middle East and Africa Biologics Drug Development Revenue by Countries (2014-2019)
9.2 Saudi Arabia Biologics Drug Development Revenue and Growth Rate (2014-2019)
9.3 UAE Biologics Drug Development Revenue and Growth Rate (2014-2019)
9.4 Egypt Biologics Drug Development Revenue and Growth Rate (2014-2019)
9.5 Nigeria Biologics Drug Development Revenue and Growth Rate (2014-2019)
9.6 South Africa Biologics Drug Development Revenue and Growth Rate (2014-2019)
10 Global Biologics Drug Development Market Segment by Type
10.1 Global Biologics Drug Development Revenue and Market Share by Type (2014-2019)
10.2 Global Biologics Drug Development Market Forecast by Type (2019-2024)
10.3 Clinical Manufacturing Revenue Growth Rate (2014-2024)
10.4 Formulation Development Revenue Growth Rate (2014-2024)
10.5 Bioassay Development Revenue Growth Rate (2014-2024)
10.6 Analytical Services Revenue Growth Rate (2014-2024)
11 Global Biologics Drug Development Market Segment by Application
11.1 Global Biologics Drug Development Revenue Market Share by Application (2014-2019)
11.2 Biologics Drug Development Market Forecast by Application (2019-2024)
11.3 In-House Revenue Growth (2014-2019)
11.4 Outsource Revenue Growth (2014-2019)
11.5 Pharma Excess Revenue Growth (2014-2019)
12 Global Biologics Drug Development Market Size Forecast (2019-2024)
12.1 Global Biologics Drug Development Market Size Forecast (2019-2024)
12.2 Global Biologics Drug Development Market Forecast by Regions (2019-2024)
12.3 North America Biologics Drug Development Revenue Market Forecast (2019-2024)
12.4 Europe Biologics Drug Development Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Biologics Drug Development Revenue Market Forecast (2019-2024)
12.6 South America Biologics Drug Development Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Biologics Drug Development Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures
Figure Biologics Drug Development Picture
Table Product Specifications of Biologics Drug Development
Table Global Biologics Drug Development and Revenue (Million USD) Market Split by Product Type
Figure Global Biologics Drug Development Revenue Market Share by Types in 2018
Figure Clinical Manufacturing Picture
Figure Formulation Development Picture
Figure Bioassay Development Picture
Figure Analytical Services Picture
Table Global Biologics Drug Development Revenue (Million USD) by Application (2015-2025)
Figure Biologics Drug Development Revenue Market Share by Applications in 2018
Figure In-House Picture
Figure Outsource Picture
Figure Pharma Excess Picture
Table Global Market Biologics Drug Development Revenue (Million USD) Comparison by Regions 2015-2025
Figure North America Biologics Drug Development Revenue (Million USD) and Growth Rate (2015-2025)
Figure Europe Biologics Drug Development Revenue (Million USD) and Growth Rate (2015-2025)
Figure Asia-Pacific Biologics Drug Development Revenue (Million USD) and Growth Rate (2015-2025)
Figure South America Biologics Drug Development Revenue (Million USD) and Growth Rate (2015-2025)
Figure Middle East and Africa Biologics Drug Development Revenue (Million USD) and Growth Rate (2015-2025)
Figure Global Biologics Drug Development Revenue (Million USD) and Growth Rate (2015-2025)
Table Abbvie Basic Information, Manufacturing Base and Competitors
Table Abbvie Biologics Drug Development Type and Applications
Table Abbvie Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Biologics Drug Development Type and Applications
Table Allergan Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Biologics Drug Development Type and Applications
Table Boehringer Ingelheim Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
Table Charles River Laboratories Basic Information, Manufacturing Base and Competitors
Table Charles River Laboratories Biologics Drug Development Type and Applications
Table Charles River Laboratories Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
Table Catalent Basic Information, Manufacturing Base and Competitors
Table Catalent Biologics Drug Development Type and Applications
Table Catalent Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
Table Lonza Group Basic Information, Manufacturing Base and Competitors
Table Lonza Group Biologics Drug Development Type and Applications
Table Lonza Group Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Biologics Drug Development Type and Applications
Table Amgen Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Biologics Drug Development Type and Applications
Table Sanofi Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
Table Global Biologics Drug Development Revenue (Million USD) by Players (2014-2019)
Table Global Biologics Drug Development Revenue Share by Players (2014-2019)
Figure Global Biologics Drug Development Revenue Share by Players in 2017
Figure Global Biologics Drug Development Revenue Share by Players in 2018
Figure Global Top 5 Players Biologics Drug Development Revenue Market Share in 2018
Figure Global Top 10 Players Biologics Drug Development Revenue Market Share in 2018
Figure Global Biologics Drug Development Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Biologics Drug Development Revenue (Million USD) by Regions (2014-2019)
Table Global Biologics Drug Development Revenue Market Share by Regions (2014-2019)
Figure Global Biologics Drug Development Revenue Market Share by Regions (2014-2019)
Figure Global Biologics Drug Development Revenue Market Share by Regions in 2018
Figure North America Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure Europe Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure South America Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Biologics Drug Development Revenue and Growth Rate (2014-2019)
Table North America Biologics Drug Development Revenue by Countries (2014-2019)
Table North America Biologics Drug Development Revenue Market Share by Countries (2014-2019)
Figure North America Biologics Drug Development Revenue Market Share by Countries (2014-2019)
Figure North America Biologics Drug Development Revenue Market Share by Countries in 2018
Figure USA Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure Canada Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure Mexico Biologics Drug Development Revenue and Growth Rate (2014-2019)
Table Europe Biologics Drug Development Revenue (Million USD) by Countries (2014-2019)
Figure Europe Biologics Drug Development Revenue Market Share by Countries (2014-2019)
Figure Europe Biologics Drug Development Revenue Market Share by Countries in 2018
Figure Germany Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure UK Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure France Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure Russia Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure Italy Biologics Drug Development Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Biologics Drug Development Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Biologics Drug Development Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Biologics Drug Development Revenue Market Share by Countries in 2018
Figure China Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure Japan Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure Korea Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure India Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Biologics Drug Development Revenue and Growth Rate (2014-2019)
Table South America Biologics Drug Development Revenue by Countries (2014-2019)
Table South America Biologics Drug Development Revenue Market Share by Countries (2014-2019)
Figure South America Biologics Drug Development Revenue Market Share by Countries (2014-2019)
Figure South America Biologics Drug Development Revenue Market Share by Countries in 2018
Figure Brazil Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure Argentina Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure Colombia Biologics Drug Development Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Biologics Drug Development Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Biologics Drug Development Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Biologics Drug Development Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Biologics Drug Development Revenue Market Share by Countries in 2018
Figure Saudi Arabia Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure UAE Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure Egypt Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure Nigeria Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure South Africa Biologics Drug Development Revenue and Growth Rate (2014-2019)
Table Global Biologics Drug Development Revenue (Million USD) by Type (2014-2019)
Table Global Biologics Drug Development Revenue Share by Type (2014-2019)
Figure Global Biologics Drug Development Revenue Share by Type (2014-2019)
Figure Global Biologics Drug Development Revenue Share by Type in 2019
Table Global Biologics Drug Development Revenue Forecast by Type (2019-2024)
Figure Global Biologics Drug Development Market Share Forecast by Type (2019-2024)
Figure Global Clinical Manufacturing Revenue Growth Rate (2014-2019)
Figure Global Formulation Development Revenue Growth Rate (2014-2019)
Figure Global Bioassay Development Revenue Growth Rate (2014-2019)
Figure Global Analytical Services Revenue Growth Rate (2014-2019)
Table Global Biologics Drug Development Revenue by Application (2014-2019)
Table Global Biologics Drug Development Revenue Share by Application (2014-2019)
Figure Global Biologics Drug Development Revenue Share by Application (2014-2019)
Figure Global Biologics Drug Development Revenue Share by Application in 2019
Table Global Biologics Drug Development Revenue Forecast by Application (2019-2024)
Figure Global Biologics Drug Development Market Share Forecast by Application (2019-2024)
Figure Global In-House Revenue Growth Rate (2014-2019)
Figure Global Outsource Revenue Growth Rate (2014-2019)
Figure Global Pharma Excess Revenue Growth Rate (2014-2019)
Figure Global Biologics Drug Development Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Biologics Drug Development Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Biologics Drug Development Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Biologics Drug Development Revenue Market Forecast (2019-2024)
Figure Europe Biologics Drug Development Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Biologics Drug Development Revenue Market Forecast (2019-2024)
Figure South America Biologics Drug Development Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Biologics Drug Development Revenue Market Forecast (2019-2024)